Cargando…
Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats
SARS-CoV-2 has exhibited varying pathogenesis in a variety of Mammalia family’s including Canidae, Mustelidae, Hominidae, Cervidae, Hyaenidae, and Felidae. Novel SARS-CoV-2 variants characterized by spike protein mutations have recently resulted in clinical and epidemiological concerns, as they pote...
Autores principales: | Hoyte, Ashley, Webster, Mark, Ameiss, Keith, Conlee, Douglas A., Hainer, Nicole, Hutchinson, Kendra, Burakova, Yulia, Dominowski, Paul J., Baima, Eric T., King, Vickie L., Rosey, Everett L., Hardham, John M., Millership, Jason, Kumar, Mahesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Zoetis Inc. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915440/ https://www.ncbi.nlm.nih.gov/pubmed/35339817 http://dx.doi.org/10.1016/j.vetmic.2022.109395 |
Ejemplares similares
-
Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021) -
Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022) -
Vaccination with an inactivated canine influenza H3N2 virus vaccine
is safe and elicits an immune response in cats
por: Velineni, Sridhar, et al.
Publicado: (2019) -
The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021) -
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)